Wells Fargo’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Sell |
33,603
-5,385
| -14% | -$54.7K | ﹤0.01% | 4041 |
|
|
2025
Q1 | $218K | Buy |
38,988
+3,131
| +9% | +$17.5K | ﹤0.01% | 4207 |
|
|
2024
Q4 | $289K | Buy |
35,857
+8,311
| +30% | +$67.1K | ﹤0.01% | 4079 |
|
|
2024
Q3 | $282K | Buy |
27,546
+767
| +3% | +$7.86K | ﹤0.01% | 3971 |
|
|
2024
Q2 | $189K | Buy |
26,779
+11,562
| +76% | +$81.7K | ﹤0.01% | 4193 |
|
|
2024
Q1 | $209K | Buy |
15,217
+1,786
| +13% | +$24.6K | ﹤0.01% | 4082 |
|
|
2023
Q4 | $124K | Buy |
13,431
+2,122
| +19% | +$19.5K | ﹤0.01% | 4373 |
|
|
2023
Q3 | $68.4K | Sell |
11,309
-5,171
| -31% | -$31.3K | ﹤0.01% | 4667 |
|
|
2023
Q2 | $128K | Buy |
16,480
+14,600
| +777% | +$113K | ﹤0.01% | 4620 |
|
|
2023
Q1 | $10.7K | Buy |
1,880
+1,431
| +319% | +$8.16K | ﹤0.01% | 5523 |
|
|
2022
Q4 | $2.65K | Buy |
449
+5
| +1% | +$29 | ﹤0.01% | 5612 |
|
|
2022
Q3 | $2K | Sell |
444
-80
| -15% | -$360 | ﹤0.01% | 5842 |
|
|
2022
Q2 | $2K | Sell |
524
-177,803
| -100% | -$679K | ﹤0.01% | 6052 |
|
|
2022
Q1 | $953K | Sell |
178,327
-3,834
| -2% | -$20.5K | ﹤0.01% | 3701 |
|
|
2021
Q4 | $2.68M | Sell |
182,161
-1,026,631
| -85% | -$15.1M | ﹤0.01% | 3019 |
|
|
2021
Q3 | $25.3M | Sell |
1,208,792
-32,489
| -3% | -$679K | 0.01% | 1443 |
|
|
2021
Q2 | $22M | Buy |
1,241,281
+37,540
| +3% | +$664K | ﹤0.01% | 1565 |
|
|
2021
Q1 | $29.5M | Buy |
1,203,741
+349,935
| +41% | +$8.57M | 0.01% | 1335 |
|
|
2020
Q4 | $28.9M | Buy |
853,806
+229,870
| +37% | +$7.78M | 0.01% | 1294 |
|
|
2020
Q3 | $15.6M | Buy |
623,936
+52,975
| +9% | +$1.32M | ﹤0.01% | 1563 |
|
|
2020
Q2 | $19.3M | Buy |
+570,961
| New | +$19.3M | 0.01% | 1390 |
|